UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeting Notch signaling pathway in cancer: Clinical development advances and challenges

Pharmacology & therapeutics (Oxford), 2014-02, Vol.141 (2), p.140-149

2014

Volltextzugriff (PDF)

New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer

Cancer treatment reviews, 2016-04, Vol.45, p.87-96

2016

Volltextzugriff (PDF)

Handbook of Therapeutic Biomarkers in Cancer

Second edition., 2021

Volltextzugriff (PDF)

DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors

Scientific reports, 2023-04, Vol.13 (1), p.5964-12, Article 5964

2023

Volltextzugriff (PDF)

Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast Cancer

Journal of clinical oncology, 2006-02, Vol.24 (5), p.769-777

2006

Volltextzugriff (PDF)

Locoregional tumor burden and risk of mortality in metastatic breast cancer

NPJ precision oncology, 2022-04, Vol.6 (1), p.22-22, Article 22

2022

Volltextzugriff (PDF)

Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update

Nature reviews. Clinical oncology, 2015-08, Vol.12 (8), p.445-464

2015

Volltextzugriff (PDF)

Phase II Trial of Ixabepilone, an Epothilone B Analog, in Patients With Metastatic Breast Cancer Previously Untreated With Taxanes

Journal of clinical oncology, 2007-08, Vol.25 (23), p.3421-3427

2007

Volltextzugriff (PDF)

TET2 and DNMT3A mutations and exceptional response to 4′-thio-2′-deoxycytidine in human solid tumor models

Journal of hematology and oncology, 2021-05, Vol.14 (1), p.1-83, Article 83

2021

Volltextzugriff (PDF)

21-Gene Recurrence Score and Survival Outcomes in the Phase III Multicenter TAILORx Clinical Trial

Journal of the National Comprehensive Cancer Network, 2024-08, Vol.22 (6), p.376-381

2024

Volltextzugriff (PDF)

Upregulation of TET2 and Resistance to DNA Methyltransferase (DNMT) Inhibitors in DNMT1-Deleted Cancer Cells

Diseases, 2024-07, Vol.12 (7), p.163

2024

Volltextzugriff (PDF)

Development and Validation of a Nomogram for Early Detection of Malignant Gallbladder Lesions

Clinical and translational gastroenterology, 2019-10, Vol.10 (10), p.e00098-e00098

2019

Volltextzugriff (PDF)

Multiplexed Cell Signaling Analysis of Human Breast Cancer Applications for Personalized Therapy

Journal of proteome research, 2008-04, Vol.7 (4), p.1508-1517

2008

Volltextzugriff (PDF)

Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Metastatic and Locally Advanced Breast Cancer

Journal of clinical oncology, 2005-04, Vol.23 (12), p.2726-2734

2005

Volltextzugriff (PDF)

Akt Phosphorylation at Ser473 Predicts Benefit of Paclitaxel Chemotherapy in Node-Positive Breast Cancer

Journal of clinical oncology, 2010-06, Vol.28 (18), p.2974-2981

2010

Volltextzugriff (PDF)

DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer

Molecular cancer therapeutics, 2012-02, Vol.11 (2), p.370-382

2012

Volltextzugriff (PDF)

Designing Phase 0 Cancer Clinical Trials

Clinical cancer research, 2008-06, Vol.14 (12), p.3675-3682

2008

Volltextzugriff (PDF)

Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up

Breast cancer research and treatment, 2019-06, Vol.175 (2), p.287-295

2019

Volltextzugriff (PDF)

Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent

Cell cycle (Georgetown, Tex.), 2011-12, Vol.10 (23), p.4074-4082

2011

Volltextzugriff (PDF)

Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors

Cancer biology & therapy, 2006-01, Vol.5 (1), p.22-27

2006

Volltextzugriff (PDF)

The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical Cancer

The journal of clinical endocrinology and metabolism, 2014-04, Vol.99 (4), p.1291-1297

2014

Volltextzugriff (PDF)

Association of Independent Prognostic Factors and Treatment Modality With Survival and Recurrence Outcomes in Breast Cancer

JAMA network open, 2020-07, Vol.3 (7), p.e207213-e207213

2020

Volltextzugriff (PDF)

Evaluation of Lymphangiogenic Factors, Vascular Endothelial Growth Factor D and E-Cadherin in Distinguishing Inflammatory From Locally Advanced Breast Cancer

Clinical breast cancer, 2012-08, Vol.12 (4), p.232-239

2012

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors

Cancer chemotherapy and pharmacology, 2015-12, Vol.76 (6), p.1273-1283

2015

Volltextzugriff (PDF)

Abstract 4722: Selective inhibition of DNA methyltransferases and efficacy of novel DNMT inhibitors in leukemia xenografts

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4722-4722

2016

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(126)

Publikationsform

Sprache

Englisch
(135)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Targeting Notch signaling pathway in cancer: Clinical development advances and challenges

New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer

Handbook of Therapeutic Biomarkers in Cancer

DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors

Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast Cancer

Locoregional tumor burden and risk of mortality in metastatic breast cancer

Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update

Phase II Trial of Ixabepilone, an Epothilone B Analog, in Patients With Metastatic Breast Cancer Previously Untreated With Taxanes

TET2 and DNMT3A mutations and exceptional response to 4′-thio-2′-deoxycytidine in human solid tumor models

21-Gene Recurrence Score and Survival Outcomes in the Phase III Multicenter TAILORx Clinical Trial

Upregulation of TET2 and Resistance to DNA Methyltransferase (DNMT) Inhibitors in DNMT1-Deleted Cancer Cells

Development and Validation of a Nomogram for Early Detection of Malignant Gallbladder Lesions

Multiplexed Cell Signaling Analysis of Human Breast Cancer Applications for Personalized Therapy

Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Metastatic and Locally Advanced Breast Cancer

Akt Phosphorylation at Ser473 Predicts Benefit of Paclitaxel Chemotherapy in Node-Positive Breast Cancer

DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer

Designing Phase 0 Cancer Clinical Trials

Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up

Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent

Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors

The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical Cancer

Association of Independent Prognostic Factors and Treatment Modality With Survival and Recurrence Outcomes in Breast Cancer

Evaluation of Lymphangiogenic Factors, Vascular Endothelial Growth Factor D and E-Cadherin in Distinguishing Inflammatory From Locally Advanced Breast Cancer

Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors

Abstract 4722: Selective inhibition of DNA methyltransferases and efficacy of novel DNMT inhibitors in leukemia xenografts

Suchergebnisse filtern